Powerful Plastic Microscope Brings Diagnostic Care to Rural Areas
By LabMedica International staff writers Posted on 02 Nov 2015 |

Image: The assembled all-plastic, 3D-printed WBC microscope on an optical bench, with one inch spacing between the holes for reference (Photo courtesy of Alessandra Forcucci).
A low-cost, miniature achromatic microscope has been fabricated for the identification of lymphocytes, monocytes, and granulocytes in samples of whole blood stained with acridine orange.
The white blood cell (WBC) differential is one component of a complete blood count (CBC), an evaluation performed for standard blood work-ups. The WBC differential count is essential at the point-of-care when screening for quantitative abnormalities in otherwise morphologically normal white blood cell populations, a condition which may occur with certain infectious diseases.
Bioengineers at Rice University (Houston, TX, USA) developed an achromatic miniature microscope, optimized for the peak emission maxima of acridine orange bound to DNA and ribonucleic acid (RNA) at 525 nm and 650 nm, respectively. It was specifically designed for the observation and classification of white blood cells in undiluted whole blood samples stained with acridine orange. By optimizing a microscope for these emission peaks, the scientists were then able to quantify the white blood cells in a sample consisting only of 20 µL of dye, 20 µL of whole blood, and a glass slide with a coverslip. The custom microscope objective was fabricated out of plastic via single point diamond turning for rapid prototyping purposes. Single point diamond turning produces plastic lenses with optical quality surface roughness.
Plastic substrates for the custom fabricated lenses were carefully selected to minimize axial chromatic aberration. The plastic objective was integrated into all-plastic, 3D-printed housing. Once the objective was initially adjusted to the proper working distance using the 3D-printed optomechanics, the system required no further manual adjustments to refocus the optics between different samples. As the sample consists of fluorescently stained undiluted blood, only one field of view was necessary to capture statistically significant information of more than 100 WBCs/field of view regarding quantities of various white blood cell types. The digital microscope classifies WBC types (lymphocytes, monocytes, granulocytes) based on the ratio of red to green intensity within each cell, rather than morphology.
The prototype microscope, which also includes an LED light source, power supply, control unit, optical system, and image sensor, cost less than USD 3,000 to construct. At production levels upwards of 10,000 units, the scientists estimate that this price would fall to around USD 600 for each unit, with a per-test cost of a few cents. Tomasz Tkaczyk, PhD, associate professor and senior author of the study, said, “One of the driving aspects of the project is the cost of the sample or sample preparation. Many systems which work for point-of-care applications use quite expensive cartridges. The goal of this study is to make it possible for those in impoverished areas to be able to get the testing they need at a manageable price point.” The study was presented on at the Frontiers in Optics 2015 meeting held during October 18–22, 2015, in San Jose (CA, USA).
Related Links:
Rice University
The white blood cell (WBC) differential is one component of a complete blood count (CBC), an evaluation performed for standard blood work-ups. The WBC differential count is essential at the point-of-care when screening for quantitative abnormalities in otherwise morphologically normal white blood cell populations, a condition which may occur with certain infectious diseases.
Bioengineers at Rice University (Houston, TX, USA) developed an achromatic miniature microscope, optimized for the peak emission maxima of acridine orange bound to DNA and ribonucleic acid (RNA) at 525 nm and 650 nm, respectively. It was specifically designed for the observation and classification of white blood cells in undiluted whole blood samples stained with acridine orange. By optimizing a microscope for these emission peaks, the scientists were then able to quantify the white blood cells in a sample consisting only of 20 µL of dye, 20 µL of whole blood, and a glass slide with a coverslip. The custom microscope objective was fabricated out of plastic via single point diamond turning for rapid prototyping purposes. Single point diamond turning produces plastic lenses with optical quality surface roughness.
Plastic substrates for the custom fabricated lenses were carefully selected to minimize axial chromatic aberration. The plastic objective was integrated into all-plastic, 3D-printed housing. Once the objective was initially adjusted to the proper working distance using the 3D-printed optomechanics, the system required no further manual adjustments to refocus the optics between different samples. As the sample consists of fluorescently stained undiluted blood, only one field of view was necessary to capture statistically significant information of more than 100 WBCs/field of view regarding quantities of various white blood cell types. The digital microscope classifies WBC types (lymphocytes, monocytes, granulocytes) based on the ratio of red to green intensity within each cell, rather than morphology.
The prototype microscope, which also includes an LED light source, power supply, control unit, optical system, and image sensor, cost less than USD 3,000 to construct. At production levels upwards of 10,000 units, the scientists estimate that this price would fall to around USD 600 for each unit, with a per-test cost of a few cents. Tomasz Tkaczyk, PhD, associate professor and senior author of the study, said, “One of the driving aspects of the project is the cost of the sample or sample preparation. Many systems which work for point-of-care applications use quite expensive cartridges. The goal of this study is to make it possible for those in impoverished areas to be able to get the testing they need at a manageable price point.” The study was presented on at the Frontiers in Optics 2015 meeting held during October 18–22, 2015, in San Jose (CA, USA).
Related Links:
Rice University
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more